newsfilter
← Latest News
GlobeNewswire·

Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSX:MDP) (OTCQX:MEDXF) today announced that it has received a Notice of Compliance ("NOC") from Health Canada to commercialize treosulfan